Drug Shortage Report for NEUROLITE
Report ID | 155417 |
Drug Identification Number | 02327848 |
Brand name | NEUROLITE |
Common or Proper name | Kit for the Preparation of Technetium Tc99m Bicisate for Injection |
Company Name | LANTHEUS MI CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BICISATE DIHYDROCHLORIDE |
Strength(s) | 0.9MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Kits of 2 and kits of 5 vials |
ATC code | V09A |
ATC description | |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2022-03-14 |
Actual start date | 2022-04-22 |
Estimated end date | 2022-07-15 |
Actual end date | 2022-08-15 |
Shortage status | Resolved |
Updated date | 2022-08-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
Company contact information | lmicanada@lantheus.com 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-08-17 | French | Compare |
v7 | 2022-08-17 | English | Compare |
v6 | 2022-04-23 | English | Compare |
v5 | 2022-04-20 | French | Compare |
v4 | 2022-04-20 | English | Compare |
v3 | 2022-03-15 | English | Compare |
v2 | 2022-02-22 | French | Compare |
v1 | 2022-02-22 | English | Compare |
Showing 1 to 8 of 8